Down 52% because their cancer drug in PH1 ,get this, might have some health side effects shown in their investor presentation poster board today.
All time lows, half of IPO price. Was $40 earlier this year.
Also this stock is part of the Tickerpoint stock program where it trades at $.05 intervals only for retail investors.
Submitted November 03, 2016 at 04:41PM by bigslimvdub http://ift.tt/2fgXc1k
No comments:
Post a Comment